PL2914136T3 - Połączenie synbiotyków do poprawy czynności mózgu - Google Patents

Połączenie synbiotyków do poprawy czynności mózgu

Info

Publication number
PL2914136T3
PL2914136T3 PL13795882T PL13795882T PL2914136T3 PL 2914136 T3 PL2914136 T3 PL 2914136T3 PL 13795882 T PL13795882 T PL 13795882T PL 13795882 T PL13795882 T PL 13795882T PL 2914136 T3 PL2914136 T3 PL 2914136T3
Authority
PL
Poland
Prior art keywords
synbiotics
combining
improve brain
brain
improve
Prior art date
Application number
PL13795882T
Other languages
English (en)
Inventor
Johan Garssen
Ruurd VAN ELBURG
Nana BARTKE
Aletta Desiree Kraneveld
Original Assignee
N.V. Nutricia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by N.V. Nutricia filed Critical N.V. Nutricia
Publication of PL2914136T3 publication Critical patent/PL2914136T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/733—Fructosans, e.g. inulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/009—Sachets, pouches characterised by the material or function of the envelope
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/519—Breve
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pediatric Medicine (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL13795882T 2012-11-02 2013-11-04 Połączenie synbiotyków do poprawy czynności mózgu PL2914136T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201261721833P 2012-11-02 2012-11-02
EP12191171 2012-11-02
PCT/NL2013/050785 WO2014070016A2 (en) 2012-11-02 2013-11-04 Synbiotics combination for brain improvement
EP13795882.3A EP2914136B1 (en) 2012-11-02 2013-11-04 Synbiotics combination for brain improvement

Publications (1)

Publication Number Publication Date
PL2914136T3 true PL2914136T3 (pl) 2021-11-29

Family

ID=47148641

Family Applications (1)

Application Number Title Priority Date Filing Date
PL13795882T PL2914136T3 (pl) 2012-11-02 2013-11-04 Połączenie synbiotyków do poprawy czynności mózgu

Country Status (12)

Country Link
US (2) US9974816B2 (pl)
EP (2) EP2914136B1 (pl)
CN (2) CN107853705A (pl)
AU (1) AU2013338705B2 (pl)
BR (1) BR112015009579B1 (pl)
ES (1) ES2884223T3 (pl)
IN (1) IN2015DN03862A (pl)
MY (1) MY173726A (pl)
PH (1) PH12015500904B1 (pl)
PL (1) PL2914136T3 (pl)
RU (1) RU2630905C2 (pl)
WO (1) WO2014070016A2 (pl)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015160234A1 (en) * 2014-04-17 2015-10-22 N.V. Nutricia Composition for brain improvement
US20150305359A1 (en) * 2014-04-24 2015-10-29 Mead Johnson Nutrition Company Nutritional compositions directed to subjects having cow's milk protein allergies
WO2016013928A1 (en) * 2014-07-24 2016-01-28 N.V. Nutricia Prevention or treatment of food allergy in infants and toddlers
EP3193886A1 (en) * 2014-09-15 2017-07-26 N.V. Nutricia Reducing anxiety in progeny
US10820616B2 (en) 2014-09-25 2020-11-03 Societe Des Produits Nestle S.A. Infant formula system with adaptive levels of human milk oligosaccharides (HMOs)
EP3223825A1 (en) * 2014-11-26 2017-10-04 Abbott Laboratories Infant formula comprising human milk oligosaccharides, polyunsaturated fatty acids, nucleotides, and lutein
EP3355878B1 (en) 2015-10-02 2024-09-25 N.V. Nutricia Glycine for use in tolerance induction in allergic patients
BR112018010505B1 (pt) * 2015-12-15 2021-11-16 Société des Produits Nestlé S.A. Composições para bebês e crianças pequenas, e uso de uma mistura sintética de hmos
AU2017251028A1 (en) * 2016-04-13 2018-11-29 Meiji Co., Ltd. Brain function-improving composition for newborns
CN109789174B (zh) * 2016-05-31 2022-08-12 森永乳业株式会社 脑功能改善剂
SG10202100843TA (en) 2016-07-28 2021-03-30 Fonterra Cooperative Group Ltd Dairy product and process
EP3522894A1 (en) * 2016-10-05 2019-08-14 N.V. Nutricia Normalization of the intestinal microbiota composition in infants or toddlers fed with an amino acid-based nutritional composition
AU2017367332B2 (en) * 2016-11-29 2020-07-23 Morinaga Milk Industry Co., Ltd. Aglycone production promoter
WO2018143793A1 (en) * 2017-02-01 2018-08-09 N.V. Nutricia Dietary modulation of brain functioning
AU2018274636B2 (en) * 2017-05-24 2024-05-02 Societe Des Produits Nestle S.A. Composition comprising Human Milk Oligosaccharides (HMO) for use in the improvement of short term memory and other cognitive benefits
EP3629770A1 (en) * 2017-05-24 2020-04-08 Société des Produits Nestlé S.A. Composition comprising oligofructose (of) for use in the improvement of short term memory and other cognitive benefits
WO2019002607A1 (en) * 2017-06-30 2019-01-03 N.V. Nutricia SYMBIOTIC COMPOSITION FOR THE PREVENTION OF DISORDERS
WO2019068356A1 (en) * 2017-10-06 2019-04-11 N.V. Nutricia PROMOTION OF COGNITIVE FUNCTIONS AFTER BIRTH OF CAESAREAN
WO2019115382A1 (en) * 2017-12-11 2019-06-20 N.V. Nutricia Composition for use for treating delayed colonization by bifidobacterium after birth
GB2590272B (en) 2018-07-13 2022-08-31 Council Scient Ind Res Synbiotic composition for improving immune response and antioxidant capacity during aging and a process for the preparation thereof
IT201900000043A1 (it) * 2019-01-03 2020-07-03 Watt S R L Sostituto della prima colazione
CN110214887B (zh) * 2019-06-28 2022-10-11 浙江大学 针对液体自冷型超高压杀菌的装置及方法
JP7406325B2 (ja) * 2019-08-08 2023-12-27 森永乳業株式会社 分離不安障害の予防又は改善のための組成物
GB2590624B (en) * 2019-12-20 2023-08-30 Green Bioactives Ltd Composition comprising one or more fructooligosaccharide(s) and L-theanine
EP3932415A1 (en) 2020-07-01 2022-01-05 Fundació Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta (IDIBGI) Gut microbiota composition and uses thereof
CN113025677A (zh) * 2021-03-12 2021-06-25 长春大学 一种以海参为原料制备免消化海参蛋白质的方法
EP4346443A1 (en) * 2021-06-02 2024-04-10 N.V. Nutricia Supplement for human milk from allergic women
CN114533765B (zh) * 2022-03-17 2023-08-25 江南大学 短双歧杆菌ccfm1025在调节幼年神经发育中的应用
WO2024254188A2 (en) * 2023-06-05 2024-12-12 Infinant Health, Inc. Methods for treating enteric injury
WO2025027192A1 (en) * 2023-08-03 2025-02-06 Mjn U.S. Holdings Llc Human milk fortifier micronutrient supplementation kit
GB2632345A (en) * 2023-08-03 2025-02-05 Mjn Us Holdings Llc Human milk fortifier micronutrient supplementation kit
WO2025058081A1 (ja) * 2023-09-14 2025-03-20 江崎グリコ株式会社 総合注意力、認知柔軟性及び／又は実行機能を改善するための組成物
WO2025242902A1 (en) * 2024-05-24 2025-11-27 N.V. Nutricia Oligosaccharide mixture for brain development
WO2025257135A1 (en) * 2024-06-10 2025-12-18 N.V. Nutricia Non-digestible oligosaccharide mixture for infants at risk of brain injury

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1065411C (zh) * 1995-06-18 2001-05-09 侯润安 新型保健营养奶粉及其生产方法
DE19961535A1 (de) 1999-12-20 2001-07-05 Vacuumschmelze Gmbh Filteranordnung
NL1014380C2 (nl) * 2000-02-14 2001-08-15 Friesland Brands Bv Darmwandversterkend voedingsmiddel.
FR2853908B1 (fr) 2003-04-16 2005-06-03 Gervais Danone Sa Produit immunomodulateur obtenu a partir d'une culture de bifidobacterium et compositions le contenant
RU2373769C2 (ru) * 2003-10-24 2009-11-27 Н.В. Нютрисиа Синбиотическая композиция для детей
AU2006217160B2 (en) * 2005-02-28 2011-09-15 N.V. Nutricia Nutritional composition with probiotics
EP1776877A1 (en) * 2005-10-21 2007-04-25 N.V. Nutricia Method for stimulating the intestinal flora
PL2164349T3 (pl) * 2006-08-04 2015-03-31 Shs Int Ltd Bezproteinowa mieszanka dla niemowląt
NL1033521C2 (nl) * 2007-03-08 2008-09-09 Friesland Brands Bv Kindervoedingen met geoptimaliseerde aminozuursamenstelling.
CN101668437A (zh) * 2007-03-13 2010-03-10 N.V.努特里奇亚 使用含有非消化性糖的组合物改善能力的方法
CN101636173A (zh) * 2007-03-27 2010-01-27 宝洁公司 施用益生菌剂的方法及试剂盒
WO2008153377A1 (en) * 2007-06-15 2008-12-18 N.V. Nutricia Nutrition with non-viable bifidobacterium and non-digestible oligosaccharide
WO2009151330A1 (en) * 2008-06-13 2009-12-17 N.V. Nutricia Nutritional composition for infants delivered via caesarean section
US20120195935A1 (en) 2009-07-27 2012-08-02 Virginia Commonwealth University Microbubble assisted viral delivery
EP2308498A1 (en) 2009-09-30 2011-04-13 Nestec S.A. Administration of Bifidobacterium breve during infancy to prevent inflammation later in life
US20110086809A1 (en) 2009-10-14 2011-04-14 Joshua Anthony Enteral Administration Of Arginine-Glutamine Dipeptide To Support Retinal, Intestinal, Or Nervous System Development
CA2778522A1 (en) 2009-10-29 2011-05-05 Nestec S.A. Nutritional compositions comprising lactoferrin and probiotics and kits of parts thereof
EP2335502A1 (en) * 2009-12-07 2011-06-22 Nestec S.A. An infant formula delivery system comprising probiotics and an infant nutritional formulation
US20110208153A1 (en) 2010-02-24 2011-08-25 John Alvey Formulations and methods for nutrient delivery
SG191393A1 (en) 2010-12-31 2013-08-30 Abbott Lab Neutral human milk oligosaccharides to promote growth of beneficial bacteria
US20130095204A1 (en) * 2011-10-14 2013-04-18 Zeina Jouni Nutritional phytonutrient compositions
RU2608232C2 (ru) 2012-01-09 2017-01-17 Н.В. Нютрисиа Обогащенная глутамином питательная композиция для недоношенных детей

Also Published As

Publication number Publication date
WO2014070016A3 (en) 2014-06-26
US20150366919A1 (en) 2015-12-24
EP3936134A1 (en) 2022-01-12
IN2015DN03862A (pl) 2015-10-02
RU2630905C2 (ru) 2017-09-14
PH12015500904A1 (en) 2015-07-13
CN107853705A (zh) 2018-03-30
US9974816B2 (en) 2018-05-22
EP3936134B1 (en) 2026-03-04
WO2014070016A2 (en) 2014-05-08
AU2013338705B2 (en) 2017-06-15
AU2013338705A1 (en) 2015-06-04
PH12015500904B1 (en) 2023-04-19
EP2914136A2 (en) 2015-09-09
CN104883908A (zh) 2015-09-02
BR112015009579A2 (pt) 2017-07-04
RU2015120800A (ru) 2016-12-27
EP2914136B1 (en) 2021-05-26
US20190076490A1 (en) 2019-03-14
MY173726A (en) 2020-02-18
BR112015009579B1 (pt) 2020-04-28
AU2013338705A2 (en) 2015-06-04
ES2884223T3 (es) 2021-12-10

Similar Documents

Publication Publication Date Title
PL2914136T3 (pl) Połączenie synbiotyków do poprawy czynności mózgu
DK2825087T3 (da) Otoscanner
EP2867548A4 (en) SELF-LOCKING FASTENING ELEMENT
DE112012006109A5 (de) Okklusionsschienenanordnung
CO6990736A2 (es) Pirrolidina-2-carboxamidas sustituídas
CL2013000381S1 (es) Motocicleta
BR302013002335S1 (pt) Configuração aplicada em porta-objetos
BR302012003344S1 (pt) Configuração aplicada a resfriador
DE112012006214T8 (de) Wulstringwickler
EP2920370A4 (en) POST
PL2900453T3 (pl) Sposób wytwarzania tubek
DE112012005566T8 (de) Seltenerdnanoverbundmagnet
EP2897218A4 (en) KOMBINATOR
FR2985656B1 (fr) Oxymetre
DE102013212400A8 (de) Abdeckplattenstützbaugruppe
GB201300324D0 (en) Improvements to letter-plates
DE202012013401U8 (de) Bioextruder
GB2507762B (en) Improvements to dartboards
DE102012100780A8 (de) Zugmittelhebevorrichtung
TH1401003459B (th) วิธีการผลิตพุดดิ้ง
TH1401007557A (th) วิธีการผลิตโพลีเอไมด์
TH1201001219B (th) วิธีการสร้างขอบล้อ
BR302012004499S1 (pt) Configuracao aplicada em mictório
BR302012004333S1 (pt) Configuracao aplicada em reômetro
BR302012003945S1 (pt) Configuração aplicada em barraca